|
US6605642B2
(en)
|
1999-04-05 |
2003-08-12 |
City Of Hope |
Inhibitors of formation of advanced glycation endproducts (AGES)
|
|
US7030133B2
(en)
*
|
1999-04-05 |
2006-04-18 |
City Of Hope |
Inhibitors of formation of advanced glycation endproducts (AGEs)
|
|
CA2368688C
(en)
|
1999-04-05 |
2009-08-11 |
City Of Hope |
Novel inhibitors of formation of advanced glycation endproducts (age's)
|
|
US7576131B2
(en)
*
|
1999-06-04 |
2009-08-18 |
Metabolex, Inc. |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
|
|
US6262118B1
(en)
*
|
1999-06-04 |
2001-07-17 |
Metabolex, Inc. |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
|
|
AU1773601A
(en)
*
|
1999-11-18 |
2001-05-30 |
John D. Bolla |
Treatment or prevention of photoaging and skin cancer
|
|
US7199259B2
(en)
*
|
2003-06-20 |
2007-04-03 |
Metabolex, Inc. |
Resolution of α-(phenoxy)phenylacetic acid derivatives
|
|
EP1682114A2
(en)
*
|
2003-10-27 |
2006-07-26 |
City of Hope |
Methods of lowering lipid levels in a mammal
|
|
WO2005115384A2
(en)
*
|
2004-05-25 |
2005-12-08 |
Metabolex, Inc. |
Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
|
|
CN1997633A
(zh)
*
|
2004-05-25 |
2007-07-11 |
麦它波莱克斯股份有限公司 |
作为ppar调节剂的取代的三唑及其制备方法
|
|
US7399493B2
(en)
*
|
2004-07-16 |
2008-07-15 |
Wille John J |
Anti-irritant botanicals
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
AU2005284908B2
(en)
|
2004-09-13 |
2011-12-08 |
Morningside Venture Investments Limited |
Biosynchronous transdermal drug delivery
|
|
US20070042026A1
(en)
*
|
2005-03-17 |
2007-02-22 |
Wille John J |
Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
|
|
WO2006127905A2
(en)
|
2005-05-24 |
2006-11-30 |
Chrono Therapeutics, Inc. |
Portable drug delivery device
|
|
US7714131B2
(en)
*
|
2005-09-23 |
2010-05-11 |
Metabolex, Inc. |
Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
|
|
WO2013006643A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
|
AU2016211330A1
(en)
|
2015-01-28 |
2017-08-03 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
|
US10679516B2
(en)
|
2015-03-12 |
2020-06-09 |
Morningside Venture Investments Limited |
Craving input and support system
|
|
CA3049529A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
US12397141B2
(en)
|
2018-11-16 |
2025-08-26 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|
|
US11865602B2
(en)
*
|
2020-01-16 |
2024-01-09 |
Ehc Inc. |
Paintless dent removal tool, system and method
|